Reply to 'Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients'

被引:2
|
作者
Cattaneo, Dario [1 ]
Gervasoni, Cristina [2 ]
机构
[1] Univ Milan, Luigi Sacco Univ Hosp, Clin Pharmacol Unit, Milan, Italy
[2] Univ Milan, Luigi Sacco Univ Hosp, Div Infect Dis 3, Milan, Italy
关键词
HIV-1-INFECTED PATIENTS;
D O I
10.1097/QAD.0b013e3283463c84
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1012 / 1013
页数:2
相关论文
共 50 条
  • [1] Reply to comment on 'pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients'
    Barrail-Tran, Aurelie
    Yazdanpanah, Yazdan
    Goldwirt, Lauriane
    Chene, Genevieve
    Colin, Celine
    Piketty, Christophe
    Bollens, Diane
    Katlama, Christine
    Descamps, Diane
    Molina, Jean-Michel
    Fagard, Catherine
    Taburet, Anne-Marie
    AIDS, 2011, 25 (07) : 1011 - 1012
  • [2] Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients
    Barrail-Tran, Aurelie
    Yazdanpanah, Yazdan
    Goldwirt, Lauriane
    Chene, Genevieve
    Colin, Celine
    Piketty, Christophe
    Bollens, Diane
    Katlama, Christine
    Descamps, Diane
    Molina, Jean-Michel
    Fagard, Catherine
    Taburet, Anne-Marie
    AIDS, 2010, 24 (16) : 2572 - 2574
  • [3] Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen
    Charpentier, Charlotte
    Roquebert, Benedicte
    Colin, Celine
    Taburet, Anne-Marie
    Fagard, Catherine
    Katlama, Christine
    Molina, Jean-Michel
    Jacomet, Christine
    Brun-Vezinet, Francoise
    Chene, Genevieve
    Yazdanpanah, Yazdan
    Descamps, Diane
    AIDS, 2010, 24 (17) : 2651 - 2656
  • [4] Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States
    Towner, William
    Lalezari, Jacob
    Sension, Michael G.
    Wohlfeiler, Michael
    Gathe, Joseph
    Appelbaum, Jonathan S.
    Bellman, Paul
    Gottlieb, Michael S.
    Ryan, Robert
    Nijs, Steven
    Hoogstoel, Annemie
    Van Solingen-Ristea, Rodica
    Witek, James
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (05) : 614 - 618
  • [5] Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients
    Dailly, Eric
    Allavena, Clotilde
    Bouquie, Regis
    Deslandes, Guillaume
    Raffi, Francois
    Jolliet, Pascale
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 42 - 46
  • [6] Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients
    Ignacio Bernardino, Jose
    Xavier Zamora, Francisco
    Valencia, Eulalia
    Moreno, Victoria
    Vergas, Jorge
    Jesus Tellez, Maria
    Estrada, Vicente
    Gonzalez-Garcia, Juan
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 180 - 181
  • [7] HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme
    Florence, E.
    De Wit, S.
    Castagna, A.
    Ribera, E.
    Hill, A.
    Vanaken, H.
    van Delft, Y.
    Marks, S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (03) : 224 - 225
  • [8] Pharmacokinetics of darunavir, etravirine and raltegravir in an HIV-infected patient on haemodialysis
    Giguere, Pierre
    la Porte, Charles
    Zhang, Guijun
    Cameron, Bill
    AIDS, 2009, 23 (06) : 740 - 742
  • [9] Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial
    Fagard, Catherine
    Colin, Celine
    Charpentier, Charlotte
    Rami, Agathe
    Jacomet, Christine
    Yeni, Patrick
    Vittecoq, Daniel
    Katlama, Christine
    Molina, Jean-Michel
    Descamps, Diane
    Chene, Genevieve
    Yazdanpanah, Yazdan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (05) : 489 - 493
  • [10] Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients
    ter Heine, Rob
    Mulder, Jan Willem
    van Gorp, Eric C. M.
    Wagenaar, Jiri F. P.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 475 - 483